Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10544467
Solid tumor methylation markers and uses thereof
granted -
US 10543221
Beta-lactamase inhibitors, formulations, and uses thereof
granted -
US 10543280
Stabilization of biomolecules using sugar polymers
granted -
US 10537528
Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds
granted -
US 10537535
Histone deacetylase inhibitors
granted -
US 10537529
Cell-free methods of producing vault particles and vault particles resulting therefrom
granted -
US 10533056
Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics
granted -
US 10533190
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10526359
Thiosaccharide mucolytic agents
granted -
US 10526619
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10517491
Cardiac phase-resolved non-breath-hold 3-dimensional magnetic resonance angiography
granted -
US 10517898
Compositions and methods related to hematologic recovery
granted -
US 10518074
Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same
granted -
US 10517942
Polypeptide glycopeptide fragments from the V1/V2 and V3 domains of the HIV-1 envelope protein gp 120
granted -
US 10520499
Methods of diagnosing and treating autism
granted -
US 10519467
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10512630
Compositions and methods for treating cancer
granted -
US 10513712
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10512669
Blockade of inflammatory proteases with cyclic peptides
granted -
US 10507284
Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type I diabetes applications
granted -
US 10507239
V1/V2 fragments of a HIV-1 envelope glycoprotein
granted -
US 10501816
Compositions and methods for detecting human pegivirus 2 (HPgV-2)
granted -
US 10500177
Glutarate compounds for treating ischemia-reperfusion injuries
granted -
US 10500271
Compositions and methods for self-adjuvanting vaccines against microbes and tumors
granted